This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hanmi Science Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Sung In Lim in Diabetes Treatment
Introduction
Sung In Lim is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of diabetes treatment through his innovative research and development.
Latest Patents
Sung In Lim holds a patent for a "Non-peptidyl polymer-insulin multimer and method for producing the same." This invention relates to a non-peptidyl polymer-insulin multimer that comprises two or more non-peptidyl polymer-insulin conjugates linked via a covalent bond. The conjugates are complexed with cobalt ions to form a multimer. This invention also includes a method and kit for preparing the multimer, as well as a pharmaceutical composition aimed at preventing or treating diabetes, which utilizes the multimer as an active ingredient.
Career Highlights
Sung In Lim is associated with Hanmi Science Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work focuses on developing effective treatments for diabetes, showcasing his commitment to improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Myung Hyun Jang and Dae Jin Kim, to further enhance the impact of his research and innovations.
Conclusion
Sung In Lim's contributions to diabetes treatment through his innovative patent highlight his role as a significant inventor in the pharmaceutical field. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile